Drug intelligence / Profile preview

CS2009 + pemetrexed

Development stage: Unknown
Lead developer: CStone Pharmaceuticals
Modality: Small Molecules, Trispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration: Intravenous

Overview

CS2009 + pemetrexed is a **combination drug therapy** currently in early clinical development for the treatment of advanced non-small cell lung cancer (NSCLC). CS2009 is a novel investigational agent (precise mechanism and structure currently not delineated in public sources) and is being studied alone or in combination with established chemotherapeutic agents. Pemetrexed is a multi-targeted antifolate chemotherapeutic that inhibits folate-dependent enzymes essential for DNA synthesis, thereby suppressing tumor cell replication[2][5]. The primary indication under investigation for this combination is advanced NSCLC[5].

Other names: CS2009 + pemetrexed

Targets

DHFR (Dihydrofolate reductase)GART (GAR transformylase)TS (Thymidylate synthase)

Beyond the preview

Go deeper on CS2009 + pemetrexed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CS2009 + pemetrexed.

Explore the full profile